India's Aurobindo Pharma Ltd. (524804.BY) said Tuesday it has received Health Canada's approval for generic versions of Pfizer Inc.'s ( PFE) Neurontin tablets to treat seizures related to epilepsy.

The Canadian regulator's approval covers 100 milligram, 300 mg and 400 mg doses of gabapentin capsules, Aurobindo Pharma said in a statement.